Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karen H. Calhoun is active.

Publication


Featured researches published by Karen H. Calhoun.


Otolaryngology-Head and Neck Surgery | 1991

CT Evaluation of the Paranasal Sinuses in Symptomatic and Asymptomatic Populations

Karen H. Calhoun; G. A. Waggenspack; C. B. Simpson; James A. Hokanson; Byron J. Bailey

The frequency of concha bullosa, paradoxical middle turbinate, and septal deviation on coronal computed tomographic scans evaluating sinus disease is known, but the incidence in normal subjects is unknown. We compared 100 consecutive scans performed for evaluation of sinus disease with 82 consecutive scans performed for evaluation of orbital pathology. Patients with sinus disease had significantly more frequent findings of disease in the osteomeatal complex and all sinuses. Concha bullosa was more common in patients with sinus disease (p < 0.05), as was septal deviation (p < 0.01). Paradoxical turbinate was equally common. Concha bullosa was associated with anterior ethmoid disease (p < 0.04). Septal deviation was associated with osteomeatal complex disease (p < 0.01) and with anterior (p < 0.04) and posterior (p < 0.04) ethmoid disease. Paradoxical turbinate was not associated with sinus abnormalities. These data imply a possible causal relationship between concha bullosa or septal deviation and sinus disease.


Laryngoscope | 1994

Distant metastases from head and neck squamous cell carcinomas

Karen H. Calhoun; Paul Fulmer; Raymond L. Weiss; James A. Hokanson

Distant metastases (DMs) occurred in 83 (11.4%) of 727 retrospectively studied head and neck cancer patients. Primary tumor location and initial treatment did not influence DM development; larger primaries (P<.04) or more extensive neck disease (P<.007) more often caused DMs. Initial diagnosis to DMs averaged 11.7 months (range, 0 to 60 months), with 84% diagnosed within 24 months. With the exception of laryngeal primaries, no facet of tumor, host, or initial treatment influenced where or how rapidly DMs developed. Lung was the most common DM site (83.4%), then bone (31.1%) and liver (6.0%). Survival with DMs averaged 4.3 months (range, 1 day to 2.7 years); 86.7% died within 1 year. This report yields the following conclusions: 1. Initial tumor size and neck disease are the only predictors of DMs. 2. DMs usually occur within 2 years of the initial diagnosis. 3. Lung is the most common DM site, making chest x‐ray the most effective DM screen. 4. Survival with DMs is usually less than a year.


Laryngoscope | 1992

Age-related changes in oral sensation

Karen H. Calhoun; Brian Gibson; Leila L. Hartley; John T. Minton; James A. Hokanson

Oral sensation (including two‐point discrimination, oral stereognosis, vibrotactile detection, somesthetic sensitivity, proprioception, and thermal sensitivity) was studied in 60 healthy adults in five age categories: 20 to 34, 35 to 49, 50 to 64, 65 to 79, and 80 years and above. Thermal and somesthetic sensitivity as well as proprioception did not change with age. Ability to differentiate tactile and vibratory sensation on the lip decreased after age 80 (P<.01), but vibration detection on the soft palate did not change. Stereognostic ability remained good up to age 80, and then declined for four of the nine shapes tested (P<.01). Two‐point discrimination deteriorated on the upper lip (P<.01), on the cheeks (P<.02), and on the lower lip (P<.06). Two‐point discrimination on the tongue and palate did not change. It was noted that oral sensation remained good with aging, showing only a slight decline in function after age 80.


Laryngoscope | 1995

Complications of endoscopic sinus surgery in a residency training program

John Kinsella; Karen H. Calhoun; Joseph J. Bradfield; John A. Hokanson; Byron J. Bailey

Endoscopic sinus surgery (ESS) is now taught in most otolaryngology residency programs in the United States. However, this is technically challenging surgery and concerns exist regarding patient safety early in the surgeons learning curve. The authors reviewed 193 cases of ESS performed by residents, under faculty supervision at our program, between 1987 and 1992. Sixty-seven percent of patients underwent bilateral anterior ethmoidectomy, 40% had bilateral total ethmoidectomy, and 44% had bilateral middle turbinate reduction. The overall complication rate was 22% and included one major complication. Synechiae accounted for 50% of minor complications. There was no correlation between middle or inferior turbinate reduction and the formation of synechiae. Posterior ethmoidectomy was not associated with a significant increase in complications. We conclude that ESS can be safely performed by otolaryngology residents in carefully structured and supervised training programs.Endoscopic sinus surgery has emerged in the last decade as the treatment of choice for chronic sinusitis. Reports of complications of the procedure from different centers vary depending on the technique used and the experience of the surgeon.


Laryngoscope | 2004

Smoking in chronic rhinosinusitis: a predictor of poor long-term outcome after endoscopic sinus surgery.

Russell D. Briggs; Steven T. Wright; Stephanie Cordes; Karen H. Calhoun

Objective This study was designed to determine whether smoking patients have poorer outcomes after endoscopic sinus surgery (ESS) based on a reliable validated rhinosinusitis‐specific quality‐of‐life outcomes test.


Annals of Otology, Rhinology, and Laryngology | 1999

Smoking Increases Facial Skin Flap Complications

John Kinsella; Christopher H. Rassekh; James A. Hokanson; Zachary D. Wassmuth; Karen H. Calhoun

This study was undertaken to determine whether smokers have a higher risk of complications after reconstruction of facial skin defects. Ninety-one patients with facial skin defects reconstructed with local flaps were reviewed retrospectively. Thirty-eight (42%) were active smokers, 12 (13%) had not smoked for at least 1 year prior to surgery, and the rest were nonsmokers. Complications occurred in 23 patients (25%; 37% in smokers, 17% in ex-smokers, and 17% in nonsmokers; p < .03). All full-thickness skin losses and all cellulitis occurred in active smokers. We conclude that active smokers are at a higher risk for complications in facial skin flap surgery. That ex-smokers had a complication rate similar to that of nonsmokers suggests that part of smokings adverse effect on skin flaps may be an acute phenomenon, and that smoking cessation for shorter (<1 year) periods of time before surgery may have a beneficial effect.


Laryngoscope | 2003

Correlation Between Facial Pain or Headache and Computed Tomography in Rhinosinusitis in Canadian and U.S. Subjects

Gordon Shields; Hadi Seikaly; Matthew LeBoeuf; Faustino C. Guinto; Herve LeBoeuf; Thomas Pincus; Karen H. Calhoun

Objectives Objectives were 1) to determine whether a correlation exists between facial pain or headache and sinus disease severity by computed tomography (CT) scan in patients with rhinosinusitis and 2) to compare disease severity and pain perception in two geographically diverse North American patient populations.


Arthritis Research & Therapy | 2006

The proinflammatory cytokines IL-1β and TNF-α induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway

Beixue Gao; Karen H. Calhoun; Deyu Fang

The overgrowth of synovial tissues is critical in the pathogenesis of rheumatoid arthritis (RA). The expression of Synoviolin (SYN), an E3 ubiquitin ligase, is upregulated in arthritic synovial fibroblasts and is involved in the overgrowth of synovial cells during RA. However, the molecular mechanisms involved in the elevated SYN expression are not known. Here, we found that SYN expression is elevated in the synovial fibroblasts from mice with collagen-induced arthritis (CIA). The proinflammatory cytokines interleukin (IL)-1β and tumor necrosis factor-α (TNF-α) induce SYN expression in mouse synovial fibroblasts. Cultivation of mouse synovial fibroblasts with IL-1β activates mitogen-activated protein kinases, including extra-cellular signal-regulated kinase (Erk), JNK (c-Jun N-terminal kinase), and p38, while only Erk-specific inhibitor blocks IL-1β-induced SYN expression. Expression of transcription factor ETS1 further enhances IL-1β-induced SYN expression. The dominant negative ETS1 mutant lacking the transcription activation domain inhibits SYN expression in a dose-dependent manner. The activation of both Erk1/2 and ETS1 is increased in the CIA synovial fibroblasts. Inhibition of Erk activation reduces ETS1 phosphorylation and SYN expression. Our data indicate that the proinflammatory cytokines IL-1β and TNF-α induce the overgrowth of synovial cells by upregulating SYN expression via the Erk1/-ETS1 pathway. These molecules or pathways could therefore be potential targets for the treatment of RA.


American Journal of Otolaryngology | 1992

Reconstruction of small- and medium-sized defects of the lower lip.

Karen H. Calhoun

Defects of up to one third of the lower lip can usually be closed primarily, using one of the excision shapes described above. Defects of 30% to 50% of the lower lip can be closed with a stair-step or lip-switch flap. In most circumstances, stair-step reconstruction attains good function more quickly than the lip switch flap and has a better aesthetic result. Defects of 50% to 75% of the lower lip can be closed with a fan flap or a Karapandzic flap; the Karapandzic flap generally provides a better functional result. Both of these flaps cause rounding of the corner of the mouth that compromise the aesthetic result.


Laryngoscope | 1997

Extended Use of Topical Nasal Decongestants

John K. Yoo; Hadi Seikaly; Karen H. Calhoun

Use of sympathomimetic topical nasal decongestants to treat nasal obstruction is usually restricted to 3 to 5 days to avoid potential rebound swelling (rhinitis medicamentosa). In this study, 10 healthy volunteers used oxymetazoline (long‐acting topical nasal decongestant) nightly for 4 weeks. Subjects who used antihistamines, oral or topical decongestants, or systemic steroids or who had active sinusitis were excluded from the study. Weekly history, physical examination, and anterior rhinomanometry revealed no adverse effects. Eight (80%) subjects developed nightly nasal obstruction a few hours before the evening dose; the obstruction resolved within 48 hours if no more decongestant was used. All subjects remained responsive to oxymetazoline 4 weeks and 8 weeks after the study began. This finding suggests that long‐acting decongestants may be safely used for longer than the recommended 3 to 5 days without adverse effects if used once nightly.

Collaboration


Dive into the Karen H. Calhoun's collaboration.

Top Co-Authors

Avatar

Francis B. Quinn

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

James A. Hokanson

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles M. Stiernberg

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Byron J. Bailey

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matthew W. Ryan

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John Kinsella

University of Texas Medical Branch

View shared research outputs
Researchain Logo
Decentralizing Knowledge